Protagonist Therapeutics (PTGX)Exceeds Revenue Estimates in Q3 2024
Protagonist Therapeutics Inc. (PTGX) is an innovative clinical-stage biopharmaceutical company that specializes in the discovery and development of…
Madrigal Pharmaceuticals (MDGL): A Financial Powerhouse With $1.0 Billion Cash Position in 2024
Madrigal Pharmaceuticals Inc. (MDGL) is a pioneering biopharmaceutical company focused on developing and commercializing novel, life-changing therapies for…
Kamada (KMDA) Reports Strong Q3 2024 Financial Results with $41.7M in Revenue
Kamada Ltd. (KMDA) is a prominent global biopharmaceutical company that has established itself as a leader in the…
Gossamer Bio (GOSS) Reports Strong Q3 2024 Financial Results
Gossamer Bio Inc. (GOSS) is a prominent clinical-stage biopharmaceutical company based in San Diego, California, committed to the…
Lakeside (LSH) Partners with Huiyu Pharmaceutical to Expand Global Oncology Drug Distribution
Lakeside Holding Limited (LSH) is a dynamic U.S.-based cross-border supply chain solution provider, strategically headquartered in Itasca, Illinois.…
Sanara MedTech (SMTI) Achieves Record $21.7M Revenue in Q3 2024
Sanara MedTech Inc. (SMTI), headquartered in Fort Worth, Texas, is a leading medical technology company dedicated to developing…
Aldeyra (ALDX) Reports $15.1M Q3 2024 Loss Amid R&D Investments
Aldeyra Therapeutics Inc. (ALDX) is a clinical-stage biotechnology company that stands at the forefront of innovation in addressing…